Why Strategy Matters in PCI

SELUTION SLR PTCA Drug-Eluting Balloon in DeNovo Lesions

Contact Us in EMEA More Product Information Request a product trial

SELUTION DeNovo PTCA Study Overview

Watch this video and enter your email, when it finishes, to receive the SELUTION DeNovo Study results as soon as they're released.

Proprietary Phospholipid Coating

Proprietary Phospholipid Coating facilitates drug uptake and retention, in the tissue, with a minimal drug loss during the procedure while providing excellent deliverability.

  • Phospholipid blend containing and protecting MicroReservoirs at 1 ug/mm2 Sirolimus Dose*
  • Enhanced drug transfer efficiency

*Cordis 2024 Data on File.

MicroReservoirs

MicroReservoirs achieve a consistent and predictable drug release, at a therapeutic level, comparable to the latest generation drug-eluting stent technology

  • ~4 um spheres of Sirolimus mixed with biodegradeable polymer
  • Sustained drug release